-
Most Popular
Search Results
240 results for abv
Why Is AbbVie Stock Down Today?
AbbVie (ABBV) stock is slipping on Friday following the release of the biopharmaceutical company’s earnings report for Q1 2022.
Gala Makes for an Intriguing Bet, But Gamble Responsibly
While cryptocurrencies represent a tough animal to figure out, gaming-centric Gala might be able to climb above the noise.
Why You Should Buy ABBV Stock for Income and Value
Although there could be further weakness in the AbbVie stock price in the coming months, ABBV stock belongs in a diversified portfolio.
AbbVie Inc Stock Soars on Strong Q4 Earnings Beat
AbbVie (ABBV) stock was flying high today following the release of a positive earnings report for the fourth quarter of 2017.
Shinzo Abe’s Kamikaze Politics
The new prime minister promises to reflate the economy to end Japan’s stagnation. Too bad that will only add to Tokyo’s crushing debt burden.
EOLS Stock: The Big News That Has Evolus Shares Skyrocketing Today
Evolus (EOLS) stock was on the rise Friday following news that it’s no longer dealing with lawsuits from AbbVie (ABBV) and Medytox.
AbbVie Stock Has a $10 Upside Opportunity — Buy It Now
There is a $10 technical opportunity in ABBV stock just around the corner. Get on board AbbVie while the value is still reasonable.
Why Best Buy Co Inc (BBY), AbbVie Inc (ABBV), Smith & Wesson Holding Corp (SWHC) are Three of Today’s Worst Stocks
Smith & Wesson (SWHC), Best Buy (BBY) and AbbVie (ABBV) got the new trading week started on the wrong foot.
Exceptional Metrics for Sales Growth Keep AbbVie (ABBV) a Strong Buy at recent price of $116.34
AbbVie Inc’s Strong Buy recommendation is the outcome of an analytical process that is proprietary and produced results that were above average in 5 areas:…
Monday’s Vital Data: Apple Inc. (AAPL), Netflix Inc. (NFLX) and AbbVie Inc. (ABBV)
A look at what has sparked some major options activity in Apple Inc. (AAPL), Netflix Inc. (NFLX) and AbbVie Inc (ABBV).
Monday’s Vital Data: Bank of America Corp (BAC), Netflix, Inc. (NFLX) and AbbVie Inc (ABBV)
Bank of America (BAC) options traders prep for earnings, Netflix (NFLX) draws a bullish brokerage note, AbbVie’s (ABBV) Imbruvica was approved in the EU.
$192 Price Target Makes AbbVie Stock a Notable Healthcare Pick
ABBV stock could have substantial room to run as a big-bank analyst assigns a high rating to relentlessly innovative AbbVie.
Consistent Clinical Results Indicate Upside for AbbVie Stock
ABBV stock can move higher as it trades at a very reasonable valuation. Meanwhile, AbbVie’s financials and dividend payments sweeten the deal.
Why AbbVie Shares Are Sliding Today
AbbVie (ABBV) stock took a hit on Thursday following comments concerning biosimilars that were made over the past couple of days.
Biopharma News: IMAB Stock Soars 4% on AbbVie Pact
I-Mab (IMAB) is seeing gains to IMAB stock on Friday after the biopharma company announced news of a deal with AbbVie (ABBV).
3 Big Stock Charts for Tuesday: Abbott Laboratories (ABT), Aetna Inc (AET) and Boston Scientific Corporation (BSX)
Abbott Laboratories (ABT), Aetna (AET) and Boston Scientific (BSX) all made bullish moves above their top bollinger bands on Monday.
Microsoft Corporation (MSFT) Will Take a Shot at All-Time Highs
Microsoft stock might not be able to sustain a run above its all-time high, but MSFT will almost certainly make a run for it soon.
Will Abe’s ‘Third Arrow’ Revive Japan?
Japanese prime minister Abe has let his “third arrow” fly. Don’t count on it shaking Japan out of its funk.
Steal Some Yield and Bet on Clinical Clout With ABBV Stock
ABBV stock investors can collect dividend payments but also expect share-price upside as AbbVie continues to clear regulatory hurdles.
AbbVie Stock Could Become a New Happy Pill for Investors
Worries about losing the Humira patent have weighed on AbbVie, but now ABBV stock brings opportunity for both growth and income investors.
AbbVie Inc Stock Dives on Lung Cancer Drug Results
AbbVie (ABBV) stock was falling hard today following results from a Phase 2 study of lung cancer drug Rovalpituzumab Tesirine.
Why AbbVie Inc (ABBV), Greif, Inc. (GEF) and Embraer SA (ADR) (ERJ) Are 3 of Today’s Worst Stocks
AbbVie (ABBV), Greif (GEF) and Embraer SA (ERJ) were at the bottom of the barrel on Thursday. This is what investors need to know about…
LinkedIn Corporation, AbbVie Inc., and Starbucks Corporation Move Big on Earnings
LinkedIn Corporation (LNKD), AbbVie Inc. (ABBV) and Starbucks Corporation (SBUX) move big in the stock market today after reporting earnings
Why AbbVie Inc (ABBV), GrubHub Inc (GRUB) and LendingClub Corp (LC) Are 3 of Today’s Worst Stocks
AbbVie (ABBV), GrubHub (GRUB) and LendingClub (LC) didn’t even have a prayer of making bullish progress on Tuesday.
10 – 10 of 240 results
